Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and doxofylline

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with doxofylline in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(doxofylline)		Trials
(doxofylline)		Recent Studies (post-2010) (doxofylline)
9,1561875521062252

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biffignandi, P; Cirillo, R; Franzone, JS1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and doxofylline

ArticleYear
Doxofylline exerts a prophylactic effect against bronchoconstriction and pleurisy induced by PAF.
    European journal of pharmacology, 1989, Jun-20, Volume: 165, Issue:2-3

    Topics: Airway Resistance; Anesthesia; Animals; Binding, Competitive; Bronchi; Bronchodilator Agents; Female; Guinea Pigs; In Vitro Techniques; Injections; Injections, Intravenous; Lung; Male; Muscle Contraction; Platelet Activating Factor; Pleurisy; Theophylline; Thromboxane A2

1989